Article
Biochemical and molecular aspects of late-onset GM2-gangliosidosis: B1 variant as a prototype.
Developmental neuroscience - 1 Jan 1991
Suzuki K, Vanier M T
Abstract excerpt
Clinical phenotypes of GM2-gangliosidosis are complex. In the past 5 years it has become possible to dissect out the phenotypic complexity on the basis of abnormalities on the DNA level. Available data on the 18 disease-causing mutations so far identified in the beta-hexosaminidase alpha-gene allow an oversimplified generalization; mutations that produce no or highly unstable mRNA cause the most severe infantile...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
